Jennifer Doss

860 total citations · 1 hit paper
10 papers, 624 citations indexed

About

Jennifer Doss is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Jennifer Doss has authored 10 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Jennifer Doss's work include RNA modifications and cancer (3 papers), Renal cell carcinoma treatment (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Jennifer Doss is often cited by papers focused on RNA modifications and cancer (3 papers), Renal cell carcinoma treatment (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Jennifer Doss collaborates with scholars based in United States, United Kingdom and France. Jennifer Doss's co-authors include Jen‐Tsan Chi, Carolyn Sangokoya, Marilyn J. Telen, Sandeep S. Davé, David L. Corcoran, Dereje D. Jima, Charles G. Drake, Patrick Williams, Gary L. Buchschacher and Karim Fizazi and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Jennifer Doss

10 papers receiving 620 citations

Hit Papers

Atezolizumab with enzalutamide versus enzalutamide alone ... 2022 2026 2023 2024 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial
    2022 157 citations Thomas Powles, Kobe Yuen et al. Nature Medicine profile →

Peers

Jennifer Doss
Guanxiong Ding China
Natasha Musrap Canada
Gloria Manzotti Italy
Rebecca Kunder United States
Valentina Rossi Italy
Daizo Oka Japan
Morane Le Hiress France
Silvia Bombelli Italy
Victoria Rimkunas United States
Giorgia Federico Italy
Guanxiong Ding China
Jennifer Doss
Citations per year, relative to Jennifer Doss Jennifer Doss (= 1×) peers Guanxiong Ding

Countries citing papers authored by Jennifer Doss

Since Specialization
Citations

This map shows the geographic impact of Jennifer Doss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Doss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Doss more than expected).

Fields of papers citing papers by Jennifer Doss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Doss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Doss. The network helps show where Jennifer Doss may publish in the future.

Co-authorship network of co-authors of Jennifer Doss

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Doss. A scholar is included among the top collaborators of Jennifer Doss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Doss. Jennifer Doss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Powles, Thomas, Kobe Yuen, Silke Gillessen, et al.. (2022). Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial. Nature Medicine. 28(1). 144–153. 157 indexed citations breakdown →
2.
3.
Sweeney, Christopher J., Silke Gillessen, Dana E. Rathkopf, et al.. (2020). Abstract CT014: IMbassador250: A phase III trial comparing atezolizumab with enzalutamide vs enzalutamide alone in patients with metastatic castration-resistant prostate cancer (mCRPC). Cancer Research. 80(16_Supplement). CT014–CT014. 47 indexed citations
4.
5.
McDermott, David F., Mahrukh Huseni, Brian I. Rini, et al.. (2017). Abstract CT081: Molecular correlates of differential response to Atezolizumab +/- Bevacizumab vs Sunitnib in a Phase II study in untreated metastatic renal cell carcinoma (RCC) patients. Cancer Research. 77(13_Supplement). CT081–CT081. 10 indexed citations
6.
Doss, Jennifer, Jude Jonassaint, Melanie E. Garrett, et al.. (2016). Phase 1 Study of a Sulforaphane-Containing Broccoli Sprout Homogenate for Sickle Cell Disease. PLoS ONE. 11(4). e0152895–e0152895. 52 indexed citations
7.
Doss, Jennifer, David L. Corcoran, Dereje D. Jima, et al.. (2015). A comprehensive joint analysis of the long and short RNA transcriptomes of human erythrocytes. BMC Genomics. 16(1). 952–952. 92 indexed citations
8.
Connelly, Jessica J., О. Е. Черепанова, Jennifer Doss, et al.. (2013). Epigenetic regulation of COL15A1 in smooth muscle cell replicative aging and atherosclerosis. Human Molecular Genetics. 22(25). 5107–5120. 56 indexed citations
9.
Sangokoya, Carolyn, Jennifer Doss, & Jen‐Tsan Chi. (2013). Iron-Responsive miR-485-3p Regulates Cellular Iron Homeostasis by Targeting Ferroportin. PLoS Genetics. 9(4). e1003408–e1003408. 93 indexed citations
10.
Connelly, Jessica J., Svati H. Shah, Jennifer Doss, et al.. (2008). Genetic and functional association of FAM5C with myocardial infarction. BMC Medical Genetics. 9(1). 33–33. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guanxiong Ding Breakdown of academic impact, for papers by Natasha Musrap Breakdown of academic impact, for papers by Gloria Manzotti Breakdown of academic impact, for papers by Rebecca Kunder Breakdown of academic impact, for papers by Valentina Rossi Breakdown of academic impact, for papers by Daizo Oka Breakdown of academic impact, for papers by Morane Le Hiress Breakdown of academic impact, for papers by Silvia Bombelli Breakdown of academic impact, for papers by Victoria Rimkunas Breakdown of academic impact, for papers by Giorgia Federico
Rankless by CCL
2026